Thermo Fisher Scientific logo

Thermo Fisher Scientific (TMO) Q1 2025 Earnings

TMO·Reported April 23, 2025·Before market open

Thermo Fisher Scientific reported Q1 2025 revenue of $10.4B (+0.2% YoY), beat analyst consensus of $10.2B by $132.1M. Diluted EPS came in at $5.15 (+0.8% YoY), beat the $5.10 consensus by $0.05. Thermo Fisher Scientific reports across 4 business segments, led by Life Sciences Solutions, Laboratory Products and Biopharma Services, and Analytical Instruments.

Revenue
$10.4Bbeat by $132.1M
Consensus: $10.2B
Diluted EPS
$5.15beat by $0.05
Consensus: $5.10
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0000097745-25-000041

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Thermo Fisher Scientific's Q1 2025 earnings report.

Thermo Fisher Scientific (TMO) reported Q1 2025 earnings on April 23, 2025 before market open.

Thermo Fisher Scientific reported revenue of $10.4B and diluted EPS of $5.15 for Q1 2025.

Revenue beat the consensus estimate of $10.2B by $132.1M. EPS beat the consensus estimate of $5.10 by $0.05.

Compared to the same quarter a year prior, revenue grew 0.2% from $10.3B a year earlier and diluted EPS grew 0.8% from $5.11.

You can read the 10-Q periodic report (0000097745-25-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.